Multiple sclerosis and Central nervous system viral infection

---

Gender of people who have Multiple Sclerosis and experienced Central Nervous System Viral Infection *:

• female: 78.57 %
• male: 21.43 %

Age of people who have Multiple Sclerosis and experienced Central Nervous System Viral Infection *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 0.0 %
• 30-39: 11.11 %
• 40-49: 33.33 %
• 50-59: 33.33 %
• 60+: 22.22 %

Common drugs taken by these people *:

1. Tysabri: 5 people, 31.25%
2. Avonex: 5 people, 31.25%
3. Tecfidera: 2 people, 12.50%
4. Rebif: 2 people, 12.50%
5. Gilenya: 2 people, 12.50%
6. Rituxan: 1 person, 6.25%
7. Ocrevus: 1 person, 6.25%

Common symptoms for these people *:

1. White Blood Cell Count Decreased: 2 people, 12.50%
2. Memory Loss: 2 people, 12.50%
3. Headache (pain in head): 1 person, 6.25%
4. Furuncle (infection of the hair follicle): 1 person, 6.25%
5. Encephalitis (inflammation of the brain): 1 person, 6.25%
6. Encephalitis Viral (inflammation of the brain due to viral infection): 1 person, 6.25%
7. Encephalomyelitis (inflammation of the brain and spinal cord): 1 person, 6.25%
8. Encephalopathy (functioning of the brain is affected by some agent or condition): 1 person, 6.25%
9. Epiglottitis (inflammation of the epiglottis): 1 person, 6.25%
10. Erysipelas (bacterial skin infection): 1 person, 6.25%

Do you take medications and have Central nervous system viral infection?

- Check whether Central nervous system viral infection is associated with a drug or a condition